Viemed Healthcare

Home-Based Respiratory Care Expansion Will Drive Long-Term Healthcare Cash Flow Tailwinds

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

10 Dec 25

n/a

AnalystConsensusTarget's Fair Value

n/a

3.9%

4.6%

3.9%

4.6%

You can edit this narrative until Dec 11 3:05 PM. Then, changes will post as Updates.

Author's Valuation

CA$18.7144.1% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

CA$18.71

44.1% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

17.82%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.93%

Calculation

US$34.36m

Earnings '26

19.26x

PE Ratio '26

US$661.92m

Market Cap '26

US$661.92m

Market Cap '26

39.46m

No. shares '26

US$16.77

Share Price '26

US$16.77 Share Price '26

Discounted to 2023 @ 5.93% p.a.

US$14.11

Fair Value '23

US$14.11 Fair Value '23

Converted to CAD @ 1.3259 USD/CAD Exchange Rate

CA$18.71

Fair Value '23